SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Maintain 6.0% Stake in Kenvue Inc.
Beneficial Ownership Report
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, disclosing a continued beneficial ownership of 6.0% of Kenvue Inc.'s common stock as of March 31, 2025.
Summary
- FMR LLC and Abigail P. Johnson collectively beneficially own 113,995,514.06 shares of Kenvue Inc. common stock.
- This aggregate ownership represents 6.0% of Kenvue Inc.'s outstanding common stock.
- FMR LLC holds sole voting power over 64,876,232.68 shares and sole dispositive power over 113,995,514.06 shares.
- Abigail P. Johnson holds sole dispositive power over 113,995,514.06 shares, with no sole or shared voting power.
- The filing is an Amendment No. 2 to Schedule 13G, indicating an update to previously reported beneficial ownership.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing the control of Kenvue Inc.
- FMR LLC is classified as a parent holding company or control person, with subsidiaries like FIAM LLC and Fidelity Management & Research Company LLC classified as investment advisers, and Fidelity Institutional Asset Management Trust Company and Fidelity Management Trust Company as banks.
- Abigail P. Johnson is a Director, Chairman, and Chief Executive Officer of FMR LLC, and a predominant owner of FMR LLC's Series B voting common shares, forming a controlling group with respect to FMR LLC.
Sentiment
Score: 6
Explanation: The filing is a routine disclosure of beneficial ownership, indicating a continued significant stake by a major institutional investor. This is generally viewed as a neutral to slightly positive signal of confidence in the company, as the investor is maintaining their position.
Positives
- The continued significant stake by a major institutional investor like FMR LLC and its principal, Abigail P. Johnson, may signal ongoing confidence in Kenvue Inc.'s business and long-term prospects.
- The filing explicitly states that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control, which suggests stability in the ownership structure.
Future Outlook
This Schedule 13G filing is a disclosure of current beneficial ownership and does not contain forward-looking statements or guidance regarding Kenvue Inc.'s future performance or strategic direction.
Management Comments
- "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."
Industry Context
This filing is a routine regulatory disclosure by a major institutional investor in the consumer health sector. Kenvue Inc. operates in this sector, and such filings provide transparency on significant ownership stakes, which is standard practice across all industries for publicly traded companies.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Ownership Structure Disclosure | Disclosure of the relationship between Abigail P. Johnson and FMR LLC, detailing her role as Director, Chairman, and CEO, and her predominant ownership of Series B voting common shares, which, through a shareholders' voting agreement, forms a controlling group with respect to FMR LLC. | NA | Provides transparency into the ultimate control and beneficial ownership structure of FMR LLC, the reporting entity, which indirectly holds a significant stake in Kenvue Inc. This clarifies the governance framework of the institutional investor, not Kenvue Inc. itself. |
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holding in Kenvue Inc., confirming the continued investment by FMR LLC and Abigail P. Johnson.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires filing of this statement (beneficial ownership calculation date). |
| 05/09/2025 | Date of filing of this Schedule 13G Amendment No. 2. |
| 01/03/2023 | Effective date of Power of Attorney for Stephanie J. Brown on behalf of FMR LLC. |
| 01/10/2023 | Date of Schedule 13G filing by FMR LLC where Power of Attorney (accession number -23-000003) was incorporated by reference. |
| 01/26/2023 | Effective date of Power of Attorney for Stephanie J. Brown on behalf of Abigail P. Johnson. |
| 01/31/2023 | Date of Schedule 13G filing by FMR LLC where Power of Attorney (accession number -23-000038) was incorporated by reference. |
Keywords
Kenvue Inc, KVUE, FMR LLC, Abigail P. Johnson, Schedule 13G, beneficial ownership, institutional investor, common stock, consumer health, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.